Chapter 56: Progress of Short-term Human Hibernation Technology
“Come on, everyone, please take a seat. I am very happy that you have joined Guangjia Technology and are willing to listen to my deception to take a chance on the future of the stars and the sea.
We have recruited a total of 2 doctors and 10 masters this time. Among them, Dr. Li graduated from Beihang University. His previous field was related to hibernation technology. Dr. Li followed me to research and implement human hibernation technology. I have a very clear idea, and the follow-up is nothing more than breaking through the technologies in the roadmap one by one.
In my opinion, this is very easy.”
Dr. Li is Li Ming. , not long after graduating from Ph.D., he was doing research and development at a foreign-funded pharmaceutical company, and was recruited even before the probation period was over.
The overall business of foreign companies in China has shrunk in recent years, especially the R&D centers of pharmaceutical companies in China. For these pharmaceutical companies, the popularity of centralized procurement in China has caused their profits to shrink. The profit shrinkage coupled with pharmaceutical research and development The gradual maturity of outsourcing has caused them to lay off their domestic R&D teams one after another.
Even though Li Ming joined the core team of this foreign company, he could not help but smell the danger and finally chose to join Guangjia Technology.
Li Ming was a little confused after hearing this. He didn’t even know that the field he was working in before was related to hibernation technology.
“The other is Dr. Hou. Dr. Hou is mainly responsible for pharmaceutical R&D outsourcing business. We will take on some pharmaceutical outsourcing business in the early stage to maintain cash flow and train the team.
Other companies will follow. After development, we will develop new drugs ourselves and will not engage in pharmaceutical outsourcing business.”
Chen Yuanguang convened his small team of 15 people, and together with Lin Jia, there were 16 people. They held the first all-staff meeting in a small conference room in Caohejing Biological Park. He stood in front and looked at the group of employees. , I feel in my heart that I have thousands of troops and thousands of heroes.
“Currently, the company mainly focuses on these two businesses. In addition, because of human hibernation technology, this technology is often seen in science fiction works, such as interstellar navigation. This technology is often involved. The male protagonist enters hibernation and wakes up. Two years later, we arrived at the target planet.
Of course, this is human hibernation technology. It is long-term human hibernation technology. What we are currently trying to achieve is short-term hibernation technology, which can allow humans to enter a state of hibernation. 3 to 10 days.
As short as three days, as long as ten days.
I divide human hibernation technology into three categories, short-term hibernation, long-term hibernation and human cryopreservation.” br>
Chen Yuanguang wrote these three categories on the whiteboard behind him, "I just briefly talked about short-term hibernation and long-term hibernation, so what is cryonics?
This is simply freezing time and reducing metabolic frequency. To the point where it can be ignored, waking up again will be decades in the future, and the hibernation state will last longer, and the measurement unit will change from years to ten years.
What we are currently trying to achieve is short-term hibernation technology." br>
After finishing speaking, the audience started to applaud, because it sounded much more reliable.
For start-ups, it is very important to let everyone know what you want to do and what your goals are, so that cohesion can be initially formed.
"In terms of pharmaceutical outsourcing, we will cooperate with companies such as Sinopharm, Fosun, and Hengrui. In the early stage, we may focus on the research and development of broad-spectrum vaccines. I am familiar with this type of business. In addition, at Renjie, we do not take orders from Zhifei Biotech. , they said they would not cooperate with me.”
Everyone present smiled in agreement. They are just a start-up company, challenging a listed company with a market value of 200 billion RMB. This matter came from Chen Yuanguang’s mouth. It came out so naturally.
The development of short-term human hibernation technology is progressing much faster than expected.
From the establishment of Guangjia Technology to the middle of the year, they initially passed experimental monkeys in the laboratory and allowed them to enter hibernation smoothly.
“Have the dividends from the Goose Factory not arrived yet?” Chen Yuanguang asked.
It's very urgent. The progress is far ahead of expectations, but almost all the money has been spent. In half a year, 50 million has been burned.
Due to the epidemic of the virus, the demand for experimental monkeys has surged. The supply has exceeded demand, causing prices to soar. The price of an experimental monkey has soared from 120,000 RMB to 500,000 RMB, which is more exaggerated than robbing money. Moreover, their hibernation technology alone is not enough to rely on experimental monkeys. It also needs to enter the clinical trial stage.
This will cost more money.
Lin Jia sighed: "The goose factory can delay it as long as possible. There is no news yet. How about we conduct the first round of financing?
I looked at the experimental results and the results are very good. If we want to sell this technology globally in the future, we will definitely need some influential financial institutions to help us accelerate the acquisition of relevant qualifications and help us build a sales system in various places.
Now is a good time to do financing. "
Chen Yuanguang said: "The problem is that the current financing is all laboratory products, and the valuation cannot go up. "
Lin Jia said: "This is not a problem. There are too many ways to invest now. We can sign and bet and set goals.
Or if you don’t mind, I can borrow money from my family? ”
Chen Yuanguang shook his head: "How much can you borrow from your family?
If you borrow more, your father won't understand this technology. If you borrow less, it will be a drop in the bucket. Just follow-up experiments, plus domestic clinical trials. In the future, I won’t be able to win more than 200 million yuan.
If I want to enter the foreign market, I talked to Sun Renjie last time, and the starting point is 1 billion yuan.”
Lin Jia thought for a while. Also, her family is in a traditional industry and is unlikely to invest money in the biomedical industry, let alone invest hundreds of millions in one investment.
“Looking for Mr. Lei?” Lin Jia asked.
Chen Yuanguang said: "You can find them, but not just one of them, find a few more, find a few more investment institutions, and finally organize them to talk together.
Let's talk first and then talk."
< br>With Chen Yuanguang’s famous endorsement, and Shen Hai’s many investment institutions, everyone is very generous, so why not take an afternoon to listen?
Foreign capital came to Sequoia and Morgan, while domestic capital came to CMB International, Shunwei Capital, Qiming Venture Partners and Materia Medica Capital.
Shunwei Capital attaches great importance to it and sent a vice president. Other investment institutions are also senior investment managers.
"We found the neurons that control metabolism in the mammalian brain, and found that hibernation-related nerves and genes exist in monkeys.
We have realized that the body can lower its body temperature and enter hibernation by itself only through external induction.< br>
Using ultrasonic induction, monkeys that were not accustomed to hibernating were put into a state of hibernation
At the same time, the experimental monkey was kept in a hibernating state for five days, and its metabolism dropped to the lowest level. Very low levels, and according to physical examination and mental state analysis, no side effects have been found so far." Chen Yuanguang briefly introduced their current results, and then continued: "The main purpose of our fundraising round is to conduct clinical experiments. First, The success of finding the relevant neurons in the human body and replicating them in the experimental monkeys”
Please read and vote for me!
(End of this chapter)